Science Day 2026
Avacta Group PLC has announced its 2026 Science Day event, titled "The Next Chapter of pre|CISION," scheduled for May 6, 2026, in Central London. The event will feature presentations from Avacta team members on the company's scientific progress and future aspirations, followed by a reception. Attendance is limited and will be allocated on a first-come, first-served basis, with a professionally recorded video of the event to be made available online for those unable to attend in person.
Select text to share a quote on X · sign in to keep highlights & notes in your AVCT notes
| LONDON and PHILADELPHIA - April 8, 2026 - Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre | CISION®, a tumor-activated oncology delivery platform, is pleased to extend an open invitation for colleagues and investors to attend the Company's 2026 Science Day: "The Next Chapter of pre | CISION." |
The Avacta Science Day event for investors will take place in Central London on May 6, 2026 commencing at 10.30 AM, at the Royal Society of Chemistry, Burlington House, Piccadilly, London W1J 0BA. Avacta team members will share presentations on the company's scientific achievements and our aspirations, to be followed by a reception for attendees.
Attendance will be limited by the capacity of the venue, so attendees will be accepted on a first come, first served basis. Investors wishing to attend should please indicate interest by email at investors@avacta.com.
For investors unable to attend in person, the event will be professionally recorded and the video made available on the Avacta website in due course.
About FAP-Exd (AVA6103)
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.